Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 2,611 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Borderline Personality Disorder, Borderline Personality, BPD - Borderline Personality Disorder
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Ischemic Preconditioning
Interventions: ischemic conditioning group; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Lack of Keratinized Gingiva
Interventions: L-PRF (Leucocyte- platelet rich fibrin), H-PRF (Horizontal -platelet rich fibrin), Surgical stent; Biological · Device
Lead sponsor: Abdo Y Ismail; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Hidradenitis Suppurativa
Interventions: Ruxolitinib Cream; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 21
States / cities: Phoenix, Arizona • Fountain Valley, California • Northridge, California + 17 more

Conditions: Stress, Anxiety, Depression, Psychological Distress, Mindfulness
Interventions: AI-Enabled Mobile App-Based Mindfulness Intervention; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Tampa, Florida

Conditions: Ileostomy - Stoma, Ileostomy; Complications
Interventions: Alfred SmartBag; Device
Lead sponsor: 11 Heath and Technologies Limited; Industry
Eligibility: 22 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Rosacea
Interventions: Anatabloc Cream, Placebo Cream; Other
Lead sponsor: Rock Creek Pharmaceuticals, Inc.; Industry
Eligibility: 25 Years to 70 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 3
States / cities: Bradenton, Florida • New Orleans, Louisiana • New York, New York

Conditions: Burn
Interventions: Sulfamylon 5% and Silver Nitrate Soaks; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 1 Day to 90 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2008
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Sexually Transmitted Diseases, Bacterial, Alcohol; Harmful Use
Interventions: Access to Game Plan app and 24-hour helpline; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 314 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Brain Concussion, Brain Trauma, Attention Concentration Difficulty, Brain Injuries, Brain Injuries, Traumatic, Neurocognitive Dysfunction, Attention Impaired, Memory Impairment, Mild Traumatic Brain Injury, Mild Cognitive Impairment
Interventions: active tDCS and cognitive training intervention, sham tDCS and cognitive training intervention; Combination Product
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Hyperpigmentation, Dark Spots
Interventions: Cosmetic dark spot corrector serum; Other
Lead sponsor: Revision Skincare; Industry
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Adherence, Patient, TB, HIV/AIDS, Care Coordination
Interventions: CHW mHealth patient intervention for trigger escalation; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Nicotine Vaping
Interventions: Kick-Nic! mobile phone application, NCI Quit Vaping website; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 12 Years to 19 Years
Enrollment: 306 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Surgical Wound
Interventions: Cetaphil Healing Ointment; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 2
States / cities: Dallas, Texas • Frisco, Texas

Conditions: Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III
Interventions: Remote Simultaneous Medical Interpreting/RSMI, Remote Consecutive Medical Interpreting/RCMI, Remote Consecutive Video Medical Interpreting/RCVI; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 8
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Glioma, Glioblastoma
Interventions: Focused ultrasound (FUS); Device
Lead sponsor: InSightec; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Baltimore, Maryland • Boston, Massachusetts • Charlottesville, Virginia + 1 more

Conditions: Type 1 Diabetes Mellitus, Adolescent Behavior, Parent-Child Relations, Communication
Interventions: MyT1DHero; Device
Lead sponsor: Michigan State University; Other
Eligibility: 10 Years to 15 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Retinoblastoma
Interventions: Carboplatin, Maxitrol®, Focal Therapy, Plaque Radiotherapy; Drug · Procedure
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 17 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN)
Interventions: The Lilac Device, Sham device; Device
Lead sponsor: Luminate Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 17
States / cities: Poway, California • Norwich, Connecticut • Hialeah, Florida + 13 more

Conditions: Denture Retention
Interventions: Investigational denture adhesive cream, Super Poligrip Free; Device
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Needle Fear, Vaccine Hesitancy
Interventions: Thimble Application; Device
Lead sponsor: Bianca Edison; Other
Eligibility: 5 Years to 11 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ptosis, Eyelid, Conjunctiva Inflamed, Eye Manifestations
Interventions: Oxymetazoline hydrochloride 0.1% ophthalmic solution, Placebo; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Macular Edema, Macular Degeneration
Interventions: Ranibizumab; Other
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Urinary Incontinence, Urinary Bladder, Neurogenic
Interventions: UroMonitor, ASCU; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Treatment of Borderline Personality Disorder With rTMS

Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage

The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing.

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Mobile Application Mindfulness

Efficacy and Application of the Alfred SmartBag System After Ileostomy Creation in Colorectal Surgery: A Pilot Study

A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks

Game Plan: Efficacy of a Brief, Web-based Intervention on Alcohol Use and Sexually-transmitted Infections

tDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study

A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation

Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA

Kick-Nic! Youth Quit Vaping App

Healing Ointment Usage Post-surgical Procedure

A Study of Language Interpretation Solutions for People With Breast Cancer

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption

Using an mHealth App to Transition Care of Type-1 Diabetes From Parents to Teens

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

A Clinical Study to Assess Force Required to Dislodge Upper Denture With and Without Use of a Novel Denture Adhesive

Thimble Mindfulness App and Recovery Patch Descriptions

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)

Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder